Cross Atlantic Partners

About The Fund

Cross Atlantic Partners is an investment firm that specializes in the healthcare and life science sectors, with a focus on drug discovery, devices, and service sectors. They operate primarily in early venture, as well as in late venture, growth capital, and Private Investment in Public Equity (PIPE) investments. Since its establishment in 1994, the firm has been dedicated to investing in private and public companies through off-market, negotiated transactions. The firm's approach is to leverage their extensive knowledge and sector expertise to identify and back promising healthcare and life science companies that demonstrate potential for substantial growth and innovation. Their strategic investments aim to support these companies through various stages of development. By providing capital, strategic guidance, and a network of healthcare industry experts, Cross Atlantic Partners looks to help their portfolio companies meet key milestones and prepare them for the next stages of growth. Although based in New York, New York, their outreach and impact span across a broader geographic area, reflecting their commitment to transform healthcare and life science landscapes. Over the years, Cross Atlantic Partners has built a reputation for their focused investment thesis and their ability to work closely with entrepreneurs to optimize both financial and strategic trajectories in the quest for healthcare advances.